Prospective Study on Intensive Early Rheumatoid Arthritis Treatment
A Phase IV Multicenter, Randomized, Double-blind Study. prospeCtive Study on Intensive Early Rheumatoid Arthritis Treatment With adalimUmab: Induction of REmission and Maintenance A Phase IV Multicenter, Randomized, Double-blind Study. prospeCtive Study on Intensive Early Rheumat ...
Rheumatoid Arthritis
Drug: adalimumab, plus prednisone;Drug: adalimumab plus placebo